Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis

LONDON, NEW YORK and HAMILTON, Bermuda, April 30, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the
global private equity firm focused on the biotechnology and pharmaceutical
industries, announced today the enrolment of the first patient into its Phase
III trial of TDT 067, terbinafine in Transfersomes(R), for the topical
treatment of onychomycosis (also known as a fungal [...]

/C O R R E C T I O N – Smith & Nephew/

MEMPHIS, Tennessee, May 4, 2010 – In the news release, New Data Reinforces the Proven Safety and Effectiveness
of the BIRMINGHAM HIP Resurfacing System, issued on 3 May 2010 23:22 GMT, by
Smith & Nephew LSE:SN over PR Newswire, we are advised by the company that
the fourteenth paragraph, first sentence, should read " To access the
conference [...]

Ansell Launches Worlds’s First Antimicrobial Surgical Glove

MELBOURNE, May 4, 2010 – Ansell today announced the launch of their new GAMMEX(R) Powder-Free
glove with AMT Antimicrobial Technology, at the Annual Congress of the Royal
Australasian College of Surgeons in Perth, Australia.

It is the first surgical glove which incorporates a proprietary
antimicrobial coating to provide an additional level of protection to
surgical [...]

Slim Down, Shape Up – National Slimming Clinics Offers Free Weight Loss Treatments to Job Seekers

LONDON, May 4, 2010 – The recession may be drawing to a close but its affects are
still gripping the UK. With unemployment levels at their highest since 1994,
finding a job has become a serious competition and those that win are not
always the ones most qualified.

National Slimming Clinics are offering to [...]

SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies

AMSTERDAM, May 3, 2010 – SynCo Bio Partners B.V., an award winning GMP biopharmaceutical
manufacturer, has expanded its current agreement with OncoMed
Pharmaceuticals, Inc., a company developing novel therapeutics that
target cancer stem cells. Under the expanded agreement, in addition to
antibody OMP-21M18, SynCo will fill batches of OncoMed's investigational
products, two additional antibodies in the OncoMed pipeline for [...]

Merck Serono Named One of the Best Places to Work in Industry by The Scientist Magazine

Merck Serono Ranked No. 24 Among the Top Life Sciences Organizations in Biotech/Pharma

GENEVA, Switzerland, May 3, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
today announced it has been named as one of the best places to work in the
industry by The Scientist magazine. Merck Serono ranked number 24 among the
top institutions. [...]

New Data Reinforces the Proven Safety and Effectiveness of the BIRMINGHAM HIP Resurfacing System

80-percent of US surgeons choose the BHR hip as it outperforms all other metal-on-metal resurfacing devices

MEMPHIS, Tennessee, May 4, 2010 – Recent new data(1) presented at this year's American Academy of
Orthopaedic Surgeons (AAOS) annual meeting reinforces the BIRMINGHAM HIP(TM)
Resurfacing (BHR) System as a safe and effective hip resurfacing device. The
multi-site study, performed by orthopedic [...]

Concentric Medical Receives Shonin Approval for Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, May 4, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced that the Merci Retriever(R),
Merci(R) Microcatheter, and Merci(R) Balloon Guide Catheter have received
Shonin approval in Japan. The Merci Retriever is a catheter-based medical
device that stroke centers use to remove blood clots from [...]

iSOFT Business Solutions Works in Partnership With Real Asset Management to Deliver a Complete Financial and Asset Management Solution

ORPINGTON, England, May 4, 2010 – iSOFT Business Solutions, the financial software, procurement
and bespoke solutions provider, today announces a partnership with Real Asset
Management (RAM), a provider of fixed asset management software and services.
The new partnership sees the integration of RAM's complete asset management
solution with iSOFT's Integra Open Enterprise suite, providing users with
fixed asset management [...]

CORD:USE, a Leader in the Cord Blood Banking Field, to Offer Its Prestigious Services to New Parents

ORLANDO, Florida, May 4, 2010 – CORD:USE Cord Blood Bank, is pleased to announce its plans to open the
CORD:USE Family Cord Blood Bank. "CORD:USE and its world class team have
decided to make available CORD:USE's high-quality cord blood banking services
to expectant parents wishing to privately bank their babies' cord blood,"
said Edward S. Guindi, M.D., CORD:USE [...]

Stemgent and Miltenyi Biotec Announce Strategic Partnership

BOSTON, Massachusetts and BERGISCH GLADBACH, Germany, May 4, 2010 – Stemgent, Inc., and Miltenyi Biotec today announced a strategic
collaboration for co-development and commercialization of stem cell research
products.

Within the strategic partnership, Miltenyi Biotec will be responsible for
worldwide marketing and sales of Stemgent's existing stem cell product
portfolio outside the USA, whereas Stemgent [...]

No More Lousy Days with Breakthrough LouseBuster(TM) Device Now Available!

SALT LAKE CITY, May 4, 2010 – Larada Sciences Inc. announced the availability of the revolutionary
FDA-cleared and CE-marked LouseBuster(TM) device
(www.lousebuster.com), which provides a new, chemical-free way to kill
head lice and their eggs using only controlled, heated air. Clinical studies
show that the device provides a safe, fast and highly effective method to
kill all stages of [...]

Kwik Fit Insurance Awarded for Mental Health Awarness

GLASGOW, Scotland, May 4, 2010 – Leading insurance intermediary Kwik Fit Insurance has been awarded the
Mental Health and Wellbeing Commendation Award from The Scottish Centre for
Healthy Working Lives.

The award has been presented in recognition of the work undertaken to
support the mental wellbeing of staff through a series of initiatives and
further [...]

Epix Pharmaceuticals, Inc. Announces the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, May 4, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties of the EP-3600 MRI imaging agent will be
auctioned on May 28, 2010. The assets of Epix were transferred to him on July
20, 2009 and [...]

Merck Serono and Fast Forward, LLC Announce First Results of Their Collaboration to Advance Drug Development in Multiple Sclerosis

Merck Serono and Fast Forward provide funding of almost $1.5 million to accelerate development of innovative drugs to repair and protect the nervous system in MS

GENEVA, Switzerland, May 5, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
and Fast Forward, LLC, a not-for-profit organization established by the
US-based National Multiple Sclerosis Society to [...]

Top-Line Human Clinical Study Results Demonstrate Safety and Preliminary Effectiveness of Cohera Medical’s TissuGlu(R)

Positive Results for Surgical Adhesive in Abdominoplasty (Tummy Tuck) Procedures Move Product Toward CE Mark Application in Europe and Clinical Study in U.S. This Year

PITTSBURGH, May 5, 2010 – Cohera Medical, Inc.(R) today announced that top-line clinical study
results demonstrate the safety and preliminary effectiveness of the company's
lead surgical adhesive product, TissuGlu(R).
[...]

Fashion Contact Lenses – Don’t Risk Damaging Your Eyes at Festivals

Contact Lens Safety is Crucial for Healthy Eyes
LONDON, May 5, 2010 – No music festival is complete without freaky interesting characters
walking around, helping to create the buzzing atmosphere that every good
festival has. You don't have to be high or drunk to the eyeballs to see
sights such as men with cannabis leaf eyes and women [...]

The Murugappa Group Achieves EBIDTA Growth of 22% PBT Grows by 29% to Rs. 1354 Crores

CHENNAI, India, May 6, 2010 – The Murugappa Group recorded significant growth in profits
during 2009-10. EBIDTA grew by 22% at Rs. 1879 Crores (LY Rs.1535 Crores) and
PBT excluding extra-ordinary income grew by 29% at Rs.1354 (LY Rs.1054
Crores). Group achieved turnover of Rs. 13617 Crores during 2009-10 (LY Rs.
15907 Crores). The drop in turnover was [...]

Cancer Supportive Care: Oral Palonosetron Approved in EU

The Second Generation 5-HT3 Receptor Antagonist Palonosetron, Already Approved as an Intravenous Solution Formulation in More Than 60 Countries Worldwide Including US, EU and Japan, Obtains the European Marketing Authorization for 0.5 mg Oral Capsules

LUGANO, Switzerland, May 10, 2010 – Palonosetron 0.5 mg soft gelatine capsule oral formulation has been
approved by the EMA (European [...]

Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.

Global Acquisition Expands Ferring's Role in Women's Health
SAINT-PREX, Switzerland, May 10, 2010 – Ferring Pharmaceuticals today announced an agreement that will expand its
Women's Health product portfolio with the acquisition of the global rights to
Xanodyne Pharmaceutical's LYSTEDA(TM) (tranexamic acid), a first-in-class,
non-hormonal therapy indicated specifically for treatment of women with
cyclic heavy menstrual bleeding (HMB). The company [...]

Health Robotics’ i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances

BOZEN, SUD-TIROL, Italy, May 10, 2010 – Health Robotics today announced i.v.STATION's certification achieving
compliance with a host of global security guidelines for controlled
substances, including tamper-evident syringe caps, biometric identification,
restricting nursing access only to ready-to-administer IVs, single-dose
storage and retrieval, etc.

"In addition to being the only company in the world proven to [...]

Lizann Prosser, Former Deloitte Director, Named New President of Crown Agents USA, Inc.

WASHINGTON, May 10, 2010 – Crown Agents USA, Inc. (CA-USA) is pleased to announce that Lizann
Prosser, former senior manager of Deloitte's Health and Social Protection
Practice, has been chosen as president of Crown Agents USA. She assumed her
new post in April 2010 becoming the CA-USA president and chief executive
officer.

Ms. Prosser is [...]

Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, May 10, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties of the EP-2104R MRI imaging agent, which
will be auctioned on May 28, 2010, include potential revenue sharing from the
first commercial sale of non-MRI imaging [...]

Gates Foundation Funds 78 New Innovative Global Health Projects Including Cell Phone Blood Tests, Carnivorous Plants and Sweat-Triggered Vaccines

Grants From 18 Countries Poised to Help Prevent and Diagnose Infectious Disease and Promote Family Health

LONDON, May 11, 2010 – The Bill & Melinda Gates Foundation today announced 78 grants of
US$100,000 each in the latest round of Grand Challenges Explorations. Grants
include the development of a low-cost cell phone microscope to diagnose
malaria, study of the [...]

PharmaTelevision Partners With Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

OXFORD, England, May 12, 2010 – PharmaTelevision(R) announced that as of today the groundbreaking online
TV channel for the BioPharma industry, is teaming up with Reuters Insider, a
new interactive on-demand video platform designed to change the way financial
professionals consume and distribute news, research and information.

"Today's generation of financial professionals access and [...]

Activity-Based Payments and Pay-for-Performance Initiatives Step up the Need for Effective Business Analytics Solutions in the European Healthcare Sector, Finds Frost & Sullivan

LONDON, May 12, 2010 – Business analytics solutions are considered the face of business
intelligence (BI) for healthcare providers, as they assist healthcare
managers and hospital management to compile, arrange and manage clinical,
financial and administrative data in a defined protocol, thereby facilitating
informed business decisions. The European healthcare sector has mostly
adopted activity-based payments. The current trend is [...]

Algorithme Pharma Announces a Strategic Appointment

LAVAL, Canada, May 12, 2010 – Doug Peel, Executive Chairman of the Board of Directors of Algorithme
Pharma, is pleased to announce the appointment of Christopher Perkin as the
company's President and Chief Executive Officer. Mr. Perkin will officially
join the company on May 31st.

This important appointment confirms Algorithme Pharma's commitment to
the development [...]

Bounty.Com Parents Poll Reveals Baby Name Regrets

LONDON, May 11, 2010 – According to a study by www.bounty.com, one in five
parents REGRET the names they have chosen for their children and 19 per cent
of folk are fed up with the sheer number of other children sharing the same
moniker.

In hindsight mums and dads claim they wouldn't have chosen
names [...]

Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division

Abbott licenses 24 Zydus pharmaceutical products for 15 high-growth emerging markets; holds option for more than 40 additional products

ABBOTT PARK, Illinois, May 11, 2010 – Further strengthening its global competitive position, Abbott (NYSE: ABT)
today announced a licensing and supply agreement with Zydus Cadila of India
for a portfolio of pharmaceutical products that Abbott will commercialize [...]

‘Depression’ is Newest Disability Intensive Course Introduced to College of Direct Support Curriculum

ATLANTA, Georgia, May 11, 2010 – The College of Direct Support (CDS), an internet-based college
for Direct Support Professionals (DSPs) and managed in partnership by
Elsevier I MC Strategies and the University of Minnesota's Research and
Training Center, has introduced its newest Disability Intensive Course (DIC)
into the CDS Curriculum – "Depression."

The course on [...]

IVT Will Demo the World’s First 3G based mHealth Solution for Three Major Chronic Diseases at ATA and INDO MEDICA

BEIJING, May 11, 2010 – IVT today announced that it has completed a major update on its Mobile
Health solution (www.mhealthservice.com/ ) and will demo the first
three 3G systems based Mobile Health solutions for three major chronic
diseases (hypertension, heart diseases and diabetes) at the coming ATA 2010
and INDO MEDICA in May. This update includes the [...]

Can Resveratrol Make You Smarter?

LONDON, May 11, 2010 – The subject of extensive studies across the world, Resveratrol is proving
to be a major talking point in the scientific community. And as evidence
comes to light of the continuing beneficial effects of this compound, a
further study by the University of Northumbria in the UK has confirmed what
many scientists already believe [...]

UBM Japan Pharma Events Grow Despite Air Travel Disruptions

AMSTERDAM, May 11, 2010 – Despite significant international travel restrictions due to the recent
Icelandic volcanic cloud, leading events organiser UBM International Media
and sister company UBM Japan Co. Ltd. today announced a record visitor
attendance of 14,435 at its 2010 Japanese Pharma events cluster, which took
place from 21-23 April at Tokyo's Big Sight Exhibition Center. Representing
an [...]

Culinary Competition Features Chefs from Around the World

NASHVILLE, Tennessee, May 11, 2010 – With culinary competitions among the most popular events in America, one
of the world's leading senior housing providers is hosting an intense cooking
competition among its culinary talent to crown Ultimate Chef America.

The competition is produced by Brookdale Senior Living and its Culinary
Arts Institute, a professional [...]

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting

PARIS, May 11, 2010 – The Combined Ordinary and Extraordinary Annual Meeting of Essilor
Shareholders was held today at Palais Brogniart in Paris under the
chairmanship of Xavier Fontanet, Chairman of the Board of Directors of
Essilor International.

Shareholders approved all of the resolutions submitted at the meeting,
including:

– The payment [...]

London Genetics Conference Proceedings Published in Drug Discovery Today

LONDON, May 12, 2010 – London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, is pleased to
announce that the importance of this approach is being highlighted with the
publication of its inaugural conference [1] proceedings in the May 2010 issue
of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To
Improve [...]

London Genetics Conference Proceedings Published in Drug Discovery Today

LONDON, May 12, 2010 – London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, is pleased to
announce that the importance of this approach is being highlighted with the
publication of its inaugural conference [1] proceedings in the May 2010 issue
of Drug Discovery Today. The conference, 'Harnessing Genetic Knowledge To
Improve [...]

IntraLinks Announces Partnership With SAFE-BioPharma; Will Provide Digital Identity Capabilities With its Life Sciences Solutions

IntraLinks will Help to Meet the Pharmaceutical Industry's Objective to Move Towards Completely Paperless Clinical Trials

NEW YORK, May 12, 2010 – IntraLinks, the leading provider of critical information exchange
solutions, today announced a partnership with SAFE-BioPharma, the non-profit
association that created and manages the SAFE-BioPharma(R) digital identity
and signature standard for the pharmaceutical and healthcare industries.
IntraLinks users, [...]

Building Contract Signed With Meander Medisch Centrum

NIEUWEGEIN, The Netherlands, May 12, 2010 – On Wednesday 12 May, Meander Medisch Centrum signed a building contract
with the executing parties for the construction of Meander Medisch Centrum's
new hospital in Amersfoort, the Netherlands. Construction will start this
summer and will be realized by Heijmans Utiliteitsbouw BV, Ballast Nedam Bouw
Speciale Projecten and Burgers Ergon. The hospital [...]

Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System

Approval Includes Specific Indication for Treatment of Diabetic Patients
NATICK, Massachusetts, May 12, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced it
has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting
Coronary Stent System, the Company's third-generation drug-eluting stent
(DES) technology. This approval includes a specific indication for the
treatment of diabetic patients. The TAXUS Element Stent [...]

West Wireless Health Institute and GE Healthcare to Collaborate on Technology and Educational Initiatives

Joint Programs to Help Advance Emerging Wireless Health Industry
SAN DIEGO, May 12, 2010 – West Wireless Health Institute (WWHI) today announced a collaboration
with GE Healthcare, a global leader in health care technology, on a variety
of research, technology and educational initiatives focused on accelerating
wireless health solutions. GE Healthcare has demonstrated innovative
leadership in the emerging wireless [...]

INTUNIV(TM) – Shire Files Suit Against Actavis Elizabeth LLC and Actavis Inc.

DUBLIN and PHILADELPHIA, May 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiary Shire LLC has filed
a lawsuit in the U.S. District Court for the District of Delaware against
Actavis Elizabeth LLC and Actavis Inc. (collectively "Actavis") for the
infringement of U.S. Patent Nos. 5,854,290 (the '290 patent), [...]

ZS Associates Wins 2010 Lilly Global Sustained Supplier Award

EVANSTON, Illinois, May 13, 2010 – Global consulting firm ZS Associates today announced that it has been
awarded the 2010 Lilly Global Sustained Supplier Award from leading
biopharmaceutical corporation Eli Lilly and Company.

The award recognizes ZS Associates' contribution to helping the
Indianapolis-based pharmaceutical company make a measurable impact on
Lilly's corporate priorities by delivering [...]

Sequent Medical Announces Closing of US$15.6 Million Venture Capital Financing

ALISO VIEJO, California, May 13, 2010 – Sequent Medical, Inc. announced today that it has closed a US$15.6
million Series B venture capital financing. The financing was led by Domain
Associates, joined by existing investors Versant Ventures and US Venture
Partners. Nimesh Shah of Domain will join Sequent's Board of Directors.

"We are privileged [...]

Biggest Study Ever Reports on Mobiles and Brain Cancer

HONG KONG, May 16, 2010 – The International Journal of Epidemiology today published a combined data
analysis from a multi national population-based case-control study of glioma
and meningioma, the most common types of brain tumour. This is the first in a
series of combined data analyses of head and neck tumours published as part
of the internationally coordinated [...]

NUTRI-FACTS Goes Online! – A New Online Information Source About Vitamins and More

BASEL, Switzerland, May 18, 2010 – Although there is copious scientific evidence to support the importance
of micronutrients such as vitamins and carotenoids for health, studies
investigating their efficacy, requirements and safety sometimes come to
conclusions that are less clear than expected or even contradict
expectations. This is actually not surprising, because the relationships
between diet, health and disease [...]

KIDS COMPANY Peace of Mind SEEKS TO PROVE THE POWER OF LOVE

Charity Embarks on Pioneering Neuroscience Research to Revolutionise Care for Vulnerable Children

LONDON, May 17, 2010 – Leading children's charity Kids Company is to research the impact of
loving care on children who have been abused and neglected. In an ambitious
research project the charity is to team up with leading British and
international childhood development clinicians to [...]

New Clinical Software Helps Women to “Win” at IVF

LONDON, May 17, 2010 – With the current trend towards personalised medicine, new software for
doctors in a clinical setting will be available from 1st June 2010, to assess
the odds of bringing home a healthy new life following in vitro fertilization
(IVF) treatment. Patients will provide the main inputs such as age, duration
of infertility and number [...]

ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology

Iobenguane I 123 Injection Studied for Its Ability to Identify Risk in Patients with Symptomatic Heart Failure (HF)

PRINCETON, New Jersey, May 17, 2010 – The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart
Failure) trial, the results of which were published in the May 18th, 2010
issue of the Journal of the American College of [...]

Neuro Drinks Launch in New York

Neuro Drinks partners with Pepsi Cola to distribute groundbreaking functional beverage brand in the greater New York City area

LOS ANGELES, May 17, 2010 – Neuro Drinks, the Southern California brand of healthy functional drinks
that enhance active lifestyles, is hitting the East Coast.
Beginning this month, Neuro Drinks will be distributed by [...]

GSMA Welcomes Publication of INTERPHONE Results

LONDON, May 17, 2010 – The GSMA welcomes the publication by the INTERPHONE study group of the
results for the combined analysis for glioma and meningioma in the
International Journal of Epidemiology.

In the press release announcing the paper Dr Christopher Wild, Director
of the International Agency for Research on Cancer (IARC) said:
[...]

Health Robotics Re-Acquires CytoCare’s European Rights from B. Braun Melsungen AG for Undisclosed Consideration

BOZEN, SUD-TIROL, Italy, May 17, 2010 – Health Robotics and B. Braun Melsungen AG today announced that in
exchange for undisclosed consideration, Health Robotics has re-acquired from
B. Braun the exclusive marketing, sales, installation, implementation,
interface, manufacturing, and technical support European rights for CytoCare,
a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and
which rights B. Braun [...]

The Election May be Over but Brown and Cameron are Still Battling, as Both Make Shortlist for Celebrity Dad of the Year

LONDON, May 17, 2010 – Gordon Brown and David Cameron have fought it out on the political
platform to be Prime Minister now they fight it out for the coveted title in
what is arguably the tougher job, being a parent.

Brown has handed over the keys of No.10 to focus time on [...]

Frost & Sullivan’s Chairman on CNBC: Unprecedented Opportunity for the UK to Develop Centres of Excellence for Smart Technologies

LONDON, May 17, 2010 – "The change in the UK government looks very good for the UK economy.
Getting spending under control is a fundamental requirement for a healthy
business economy. At the same time, the support for innovation and
entrepreneurship is very important to take advantage of the next economic
boom which will be centred on innovation [...]

Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-3600 MRI Imaging Agent

WELLESLEY HILLS, Massachusetts, May 17, 2010 – Joseph F. Finn, Jr., C.P.A. ("Finn"), Assignee for the Benefit of
Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the
MRI imaging intellectual properties of the EP-3600 MRI imaging agent, which
will be auctioned on May 28, 2010, include potential royalties of 2% each
from the development and commercialization of [...]

TAIJI Announces Official Operation of Its Sintering FGD Project for Tangshan

NINGBO, China, May 18, 2010 – Ningbo Taiji Environmental Protection Equipment Co., Ltd. (TAIJI)'s FGD
(Flue-gas desulfurization) technology was officially put into operation,
successfully being used in 230 m2 sintering. For the project, TAIJI chose to
use steel slag as an absorbent instead of lime or other absorbents
traditionally used in desulfurization. In comparison to the use of [...]

Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)

Amidst Industry Unrest due to Drug Pricing Benchmark Upheaval, Gold Standard/Elsevier to Continue Publishing AWP and Other Pricing Standards

TAMPA, Florida, May 18, 2010 – Gold Standard/Elsevier, publisher of drug information databases and
decision support solutions, has announced its commitment to continue
publishing transparent drug pricing information, including average wholesale
price (AWP) and all other current and future [...]

Frost & Sullivan Web Conference on the European Melanoma Skin Cancer Market: Will the Drugs in Pipeline Deliver?

LONDON, May 18, 2010 – There are only two FDA/EMEA approved drugs currently available for
treating advanced melanoma. The available drugs, however, are not completely
effective and have adverse effects. Unmet needs of patients, especially those
with advanced melanoma are therefore quite high and have led to a low drug
adoption and market growth over the years. The [...]

IDEV Technologies Announces European Launch of SUPERA VERITAS(TM) Stent Delivery System

Innovative Technology Provides Precision, Ease of Use For Delivery of SUPERA(R) Stent

WEBSTER, Texas, May 18, 2010 – IDEV Technologies, Incorporated, (IDEV) an emerging leader in the
development and marketing of minimally invasive medical technologies, today
announced the European launch of the SUPERA VERITAS(TM) Peripheral Vascular
System, a novel and innovative stent delivery system designed to be reliable,
easy [...]

Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification

CLEVELAND, Ohio, May 18, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is proud to report that their ANGIO Mentor virtual
reality simulator was used during the 4th International Congress of the
Polish Vascular Societies in April 2010 for the training and certification [...]

Accuray Hires General Manager for the EIMEA Region

SUNNYVALE, California, May 18, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, announced today that Vittorio Puppo, M.D., has joined Accuray
as General Manager of the EIMEA (Europe India Middle East and Africa) region,
effective May 17, 2010.

Prior to joining Accuray, Puppo worked for Covidien, a healthcare [...]

Chiltern Announces New Offices and Expansion Plans in Asia Pacific

LONDON, May 18, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO) has announced its expansion plans in Asia Pacific.

Chiltern has established two new offices and launched operations in
Australia and Singapore – with Singapore acting as the hub for its operations
in Southeast Asia. This builds further upon Chiltern's [...]

Breathe Technologies Secures US$23 Million in Series C Financing

John Miclot elected chairman; FDA clearance received.
SAN RAMON, California, May 18, 2010 – Breathe Technologies, Inc., a manufacturer of innovative technology
solutions for people with respiratory conditions, including chronic
obstructive pulmonary disease and sleep apnea, announced today it has secured
US$23 million in Series C financing. The financing was led by DAG Ventures
and included Kleiner Perkins Caufield [...]

Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research

CALGARY, Canada, May 18, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced
today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of
Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients
with Advanced Cancers," has been published in the online version of the
journal Clinical Cancer Research.

The paper covers final results [...]

Reach the core of sexuality with Kamagra Jelly

Kamagra jelly has been the genuine form of Generic Viagra. It is the best online form of medication that works in dealing with male impotence. Erectile dysfunction (ED) or impotence is a male sexual syndrome that affects the quality of sex life. It is the inability of the sexually aroused man to attain a penile [...]

Ghana Pharmaceuticals and Healthcare Report Q2 2010

Dallas, TX: ReportsandReports announce it will carry Ghana Pharmaceuticals and Healthcare Report Q2 2010 Market Research Report in its Store.

BMI’s new Ghana pharmaceuticals and healthcare report includes top-line pharmaceutical market and healthcare spending data through to 2019, including our views on growth drivers in this sector. Pharmaceutical spending in Ghana is expected to rise at [...]

Remote & Wireless Patient Monitoring Markets

Dallas, TX: ReportsandReports announce it will carry Remote & Wireless Patient Monitoring Markets Market Research Report in its Store.

Patient monitoring systems are emerging in response to increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness.
Of these new [...]

M&As on the Rise in the European Medical Imaging Market as Market Leaders Focus on Expanding their Share in Emerging Markets, Says Frost & Sullivan

LONDON, May 19, 2010 – There has been an increasing number of mergers and acquisitions (M&As) in
the European medical imaging market with market leaders focussing on
acquisitions to expand their share in emerging markets. Drug makers, research
labs, equipment manufacturers and healthcare technology companies have been
the active acquirers, whereas hospitals, insurers and pharmacological
companies have a limited [...]

Shire Receives 2010 Corporate Award From the National Organization for Rare Disorders (NORD) for the Development of VPRIV (velaglucerase alfa for Injection)

Organization Recognizes Shire's Commitment to the Gaucher Disease Community

CAMBRIDGE, Massachusetts, May 19, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that it has received the 2010
Partners in Progress Corporate Award from NORD. Shire was recognized for its
efforts to accelerate the development of VPRIV(TM), a human cell line derived
enzyme [...]

Essilor Sells its Stake in Sperian Protection

CHARENTON-LE-PONT, France, May 19, 2010 – Sperian Protection's Board of Directors agreed this morning to
accept Honeywell's voluntary tender offer to acquire 100% of its capital at a
price of EUR117 per share.

Essilor has agreed to sell all of its Sperian Protection
shares to Honeywell in an off-market transaction, based on the offering [...]

AMT Provides Business Update for the First Quarter 2010

AMSTERDAM, May 19, 2010 – Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in
the field of human gene therapy, today provides its non-audited business
update in compliance with the EU transparency directive. This report
summarizes material events and AMT's financial position for the first quarter
of 2010.

Q1 2010 Highlights

– [...]

The French Competition Authority Follows up Allegations of Anti-competitive Practices by Sanofi-Aventis to Exclude Fair Generic Competition for Plavix(R) (clopidogrel)

UTRECHT, The Netherlands, May 19, 2010 – Teva Sant??, one of France's leading generic medicines
companies, has welcomed news that the French Competition Authority has agreed
to its request to investigate alleged anti-competitive practices by
Sanofi-Aventis aimed at preventing generic competition to its Plavix(R)
(clopidogrel) treatment.

In November last year, Teva Sant?? filed a complaint [...]

Elsevier/MC Strategies Partners with American Association of Critical-Care Nurses to Launch Interactive, Online Pharmacology Course

Critical Care Pharmacology Course Promotes Patient and Drug Administration Safety

ATLANTA, Georgia, May 20, 2010 – Elsevier/MC Strategies (www.mcstrategies.com/), a
pioneer in providing e-learning solutions to more than 1,300 healthcare
organizations, has partnered with the American Association of Critical-Care
Nurses (AACN) to develop a series of online nursing courses. Today, AACN and
Elsevier/MC Strategies announced the first course in [...]

Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB

BARCELONA, Spain, May 20, 2010 – Today, Grifols SA announced that it has reached an agreement with the
Swedish company Pharmalink AB to acquire various forms of intellectual
property (IP) associated with the treatment of post-polio syndrome (PPS). The
acquisition is expected to be finalized in the next few weeks and will
include documentation, know-how, and Swedish regulatory [...]

Abbott to Present New Clinical Data on Current and Future Innovations in Interventional Cardiology at EuroPCR 2010

Abbott's Leadership in the Vascular Device Industry is Highlighted with Four Late-Breaking Trials

ABBOTT PARK, Illinois, May 20, 2010 – Abbott (NYSE: ABT) today announced the company's schedule of key news
announcements and events during the EuroPCR 2010 conference in Paris, May 25
- 28. Highlights include four late-breaking clinical trial presentations on
Abbott's broad portfolio of vascular [...]

Frost & Sullivan’s GIL 2010: Europe – Innovation and Entrepreneurship Unlock Powerful Opportunities

LONDON, May 20, 2010 – Over 400 industry luminaries, visionaries and leaders gathered together
this week at London's Emirates Stadium for Frost & Sullivan's annual
gathering – the Global Growth, Innovation & Leadership Congress, GIL 2010:
Europe. This year's theme focused largely around leveraging innovation as a
resource to help shape a better future of our companies and [...]

IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer

Provides Significant and Broad Expertise in Clinical Trials, Regulatory Affairs

WEBSTER, Texas, May 24, 2010 – IDEV Technologies, Incorporated, (IDEV) an emerging leader in the
development and marketing of minimally invasive medical technologies, today
announced that veteran healthcare executive Dennis Donohoe, M.D., has been
named Chief Medical Officer. Dr. Donohoe reports directly to President and
Chief Executive Officer Christopher [...]

Mindray Recognised by Frost & Sullivan for Its Global Expansion and Acquisition Strategy

LONDON, May 24, 2010 – Based on its recent analysis of the patient monitoring market, Frost &
Sullivan recognises Mindray Medical International Limited (Mindray) with the
"2010 European Patient Monitoring Excellence in Globalisation Award."
Mindray, which maintains its global base for product development, engineering
and manufacturing in China, employs a vertically integrated operating model
that enables the company to [...]

Neusoft Medical Wins 2010 Frost & Sullivan New Product Innovation Award

SHENYANG, China, May 24, 2010 – Neusoft Medical Systems Co., Ltd. (Neusoft Medical), a wholly-owned
subsidiary of Neusoft Corporation (600718.SH), which is a leading IT
solutions & services provider in China, announced today that it received
"2010 Frost & Sullivan New Product Innovation Award" from Frost & Sullivan, a
world-renowned consulting and research corporation, for its remarkable
contribution to [...]

Health Robotics and McKesson to Showcase i.v.STATION and i.v.SOFT at ASHP’s Summer Meeting, Tampa, June 6-8, 2010

BOZEN, Sud-Tirol, Italy, May 24, 2010 – Health Robotics today announced that on the heels of the recently
announced Health Robotics-McKesson exclusive partnership [
www.pr-inside.com/mckesson-expands-i-v-automation-portfolio-r1873650.h
tm] i.v.SOFT and i.v.STATION new product designs and Q&A sessions will be
held at the McKesson booth [701] of the American Society of Health-System
Pharmacists' Summer Meeting (ASHP) in Tampa, Florida, June 6-8, 2010.

[...]

Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting

CLEVELAND, Ohio, May 24, 2010 – Simbionix USA Corporation, the world's leading provider of medical
education and simulation training products for medical professionals and the
healthcare industry, is launching two new hands-on training systems- the Lap
Nepherctomy simulation module and the VirtaMed TURPSim. Both solutions will
be revealed for the first time at the AUA annual meeting in [...]

CID Vascular Sponsors Tech News & Trends at Euro PCR 2010

PARIS, May 26, 2010 – CID Vascular, a leader in interventional medicine, is sponsoring Tech
News & Trends at Euro PCR on May 26th in Paris. The two-hour session will
explore issues surrounding the complex decisions doctors must make when
implanting coronary stents in patients with conditions that affect blood
clotting.

Two live cases performed [...]

For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System

InspireMD is Also Proud to Announce That MGuard(TM) is Now Available With an Improved Delivery System

PARIS, May 26, 2010 – InspireMD, Ltd. announced today the next generation MGuard stent,
MGuard Prime(R), a net protective Cobalt Chromium stent system. MGuard
Prime(R) offers an advanced patented Cobalt Chromium design, superior
flexibility and excellent deliverability on top of the established [...]

Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System

Randomized Study of Nearly 3,000 Patients to Evaluate Company's Third-Generation Drug-Eluting Stent Technology

NATICK, Massachussetts, May 26, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced the
initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored
research (ISR) study designed to compare the performance of the PROMUS(R)
Element(TM) Everolimus-Eluting Coronary Stent System to the XIENCE PRIME(TM)
Everolimus-Eluting Coronary Stent [...]

Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States

Company Supplements Broad RNAi IP Portfolio and Strengthens Growing Position in Oncology

LONDON, May 26, 2010 – Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company")
announces the issuance of United States patent 7,723,316, titled Compositions
and Methods of RNAi Therapeutics For Treatment of Cancer and Other
Neovascularization Disease, by the United States Patent and Trademark Office
(USPTO). The [...]

First Coronary Stent on Drug Eluting Balloon Implanted

Innovation Improves Patient's Comfort and Reduces Procedure Cost Significantly

HELMOND, The Netherlands, May 25, 2010 – Blue Medical today announced a major step forward in its quest to improve
the quality of life of patients with cardiovascular disease, with the start
of the PIONEER trial, in which a new safe concept of stent-drug combination
is evaluated.
[...]

Cancer Detection at Your Fingertips: Bioholo-tomography Promises Enormous Growth Potential, According to Frost & Sullivan

LONDON, May 25, 2010 – As the potential cancer population increases, an effective long-term
solution for early cancer detection needs to be found. In some areas of the
world, cancer incidence is growing by 3 per cent per annum, and the cost of
cancer care is a ticking time bomb for global healthcare expenditure.

[...]

Philips Unveils Concepts of Future Living to Launch Livable Cities Awards

AMSTERDAM, May 25, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today gave a glimpse of
what our future living environments could be like with the unveiling of three
concepts – 'Healing Bed', 'Air Tree' and 'Soundbarrier'. All three concepts
aim to reconnect us with the natural environment, an increasingly rare
commodity in a today's urbanized world. [...]

Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

CALGARY, Canada, May 25, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC,
NASDAQ:ONCY) today announced that it has opened enrollment in its Phase 3
trial examining REOLYSIN in combination with paclitaxel and carboplatin in
patients with platinum-refractory head and neck cancers. The Company had
previously received approval from the U.S. Food and Drug Administration (FDA)
under the Special Protocol Assessment [...]

Abbott’s Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves

Preliminary Results Also Show MitraClip Device Maintains Durability through Two Years in Patients Treated for Mitral Regurgitation

PARIS, May 25, 2010 – Abbott (NYSE: ABT) today announced new data from the landmark EVEREST II
(Endovascular Valve Edge-to-Edge REpair STudy) trial, which provide
additional details about the safety and clinical benefit of Abbott's
investigational MitraClip(R) system for the two [...]

New Data Reinforces Safety Profile of Abbott’s Market-Leading XIENCE V(R) Drug Eluting Stent

In XIENCE V USA Study, XIENCE V Demonstrates Low Blood Clot Rate at One Year in Real-World Patient Population

PARIS, May 25, 2010 – Two late-breaking clinical trials presented today at the EuroPCR 2010
conference reinforced the outstanding clinical data supporting Abbott's
market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System. In the
XIENCE V USA study of more [...]

NEVO(TM) Sirolimus-Eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data

NEVO(TM), Incorporating RES TECHNOLOGY(TM), Continues to Support Excellent Safety and Efficacy Outcomes vs. the Taxus(R) Liberte(R) According to Data Presented at EuroPCR 2010

PARIS, May 25, 2010 – At 12 months the NEVO(TM) Sirolimus-eluting Coronary Stent has continued
to demonstrate excellent safety and efficacy outcomes compared to Taxus(R)
Liberte(R) according to new data presented today from the [...]

Edwards SAPIEN Transcatheter Heart Valve Shows Positive One-Year Outcomes in Rigorous Post-Market Study

PARIS, May 25, 2010 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, today announced that
Martyn Thomas, M.D., reported that the Edwards SAPIEN transcatheter heart
valve demonstrated promising one-year mortality rates for high-risk patients,
many of whom were too sick to undergo traditional open-heart surgery. The
1,038-patient SOURCE Registry [...]

Spa & Resort/Medical Aesthetics Conference and Expo to Be Held September 28-29, 2010

Premier Event for Beauty Care, Skin Care and Spa Professionals Returns to New York

NEW YORK, May 25, 2010 – The Spa & Resort/Medical Aesthetics Conference and Expo
(www.spaandresortexpo.com) will return to New York this fall to educate,
inspire, and empower beauty, skin care, and wellness professionals. The
two-day trade show will take place from September 28-29, 2010 [...]

Abbott’s Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results

New Six-Month Data on Abbott's Bioresorbable Vascular Scaffold Reinforces Its Potential to Be the Next Revolution in Interventional Cardiology

PARIS, May 25, 2010 – Abbott (NYSE: ABT) today announced positive six-month results from the
first 45 patients enrolled in the second stage of the ABSORB trial, which was
presented during the Late-Breaking Clinical Trials session at the [...]

Heptares Therapeutics Extends Multi-FTE Chemistry Collaboration With Oxygen Healthcare (O2h)

CAMBRIDGE, England, May 25, 2010 – Executives from Heptares Therapeutics (Welwyn Garden City, UK)
and O2h (Cambridge, UK) announced today an extension of the agreement under
which O2h provides multi-FTE -synthetic chemistry services to support
discovery programmes at Heptares.

Dr. Miles Congreve, Head of Chemistry said, "We are happy to have signed
this new contract [...]

First Major Survey of Multiple Sclerosis (MS) Nurses Highlights Significant Disparities in MS Nursing Across Europe

The Findings from MS-NEED (Multiple Sclerosis-Nurse Empowering EDucation): European Survey Highlights the Need to Define and Benchmark Healthcare Provision in MS Across Europe

BRUSSELS, May 26, 2010 – The first major survey of European Multiple Sclerosis (MS) nurses
revealed that nearly one in three nurses (31%) reported that standards of
MS care are not adequately maintained in [...]

Systech International and Videojet Brazil Partner to Meet Brazil’s Emerging Pharmaceutical Regulatory Requirements

Videojet Brazil will sell, install and support the Systech serialization solution, enabling life science manufacturers distributing product in Brazil to efficiently address track and trace initiatives

BRUSSELS, Belgium and SAO PAULO, Brazil, May 26, 2010 – Systech International, innovator of Packaging Execution Systems (PES)
(www.systech-tips.com/pes.php), and Videojet Brazil, a leading
supplier of encoding and marking solutions, today [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

NEWS HIGHLIGHTS

– Intel is expanding availability of the Intel Health Guide
across Europe to help address chronic care challenges

– [...]

Trimega Sponsors Gwede Mantashe Event

CEO Adopts Role of 'Global South African'
LONDON, May 26, 2010 – UK-headquartered substance abuse testing company – Trimega Laboratories -
has been invited to sponsor an exclusive briefing event in London at which
the Secretary General of the African National Congress, Mr Gwede Mantashe,
will deliver a keynote speech.

The cocktail briefing is taking [...]

GAIN Calls on Leaders to Tackle the ‘Double Burden’ of Malnutrition in the MENA Region

DUBAI, UAE, May 26, 2010 – While wealthy Gulf States are grappling with a new epidemic of obesity,
millions across the Middle East and North Africa still suffer the hidden
hunger of under-nutrition.

This is the 'double-burden' of malnutrition in the MENA region and both
conditions are rooted in poor diet lacking in vitamins [...]

Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology

TREK Reflects a Leap in Balloon Design, with 10 Changes from 'Tip to Hub' for Improved Performance

PARIS, May 26, 2010 – Abbott (NYSE: ABT) today announced the European approval and launch of
its TREK(TM) Coronary Dilatation Catheter for the treatment of coronary
artery disease. The TREK system represents a new approach to balloon catheter
design, and provides [...]

Amira Announces Second DP2 Antagonist Patent Grant in the United Kingdom

Patent Covers Novel DP2 (CRTH2) Receptor Antagonists for the Treatment of Respiratory Disorders

SAN DIEGO, May 26, 2010 – Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual
Property Office has granted patent number GB2461629, titled, "HETEROALKYL
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS," which includes coverage of
Amira's AM461 DP2 receptor antagonist.
This is the second [...]

The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott’s Carotid Stent System and Surgery

Company Plans to File Application by End of Year Seeking an Expanded Indication to Treat Standard-Surgical-Risk Patient Population

ABBOTT PARK, Illinois, May 26, 2010 – Data from the CREST (Carotid Revascularization Endarterectomy vs.
Stenting Trial) study were published today in The New England Journal of
Medicine. In this trial, stenting and surgery had similar initial safety and
longer-term [...]

Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union

Given as an Injection Every Six Months, Prolia Reduced the Risk of Fractures in Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fractures

THOUSAND OAKS, California, May 28, 2010 – Amgen Inc. (Nasdaq: AMGN) today announced that the European Commission
(EC) has granted marketing authorization for Prolia(R) (denosumab) for the
treatment of osteoporosis in postmenopausal [...]

FirstAidWarehouse.co.uk Examines High Blood Pressure, or Hypertension, and Blood Pressure Monitors

YORK, England, May 28, 2010 – High blood pressure is a leading cause of deaths in the world. Apart from
millions with diagnosed hypertension, still many others are borderline
hypertensive. High blood pressure increases the risk of a person to develop
cardiovascular diseases, kidney problems, heart attack and even a stroke. One
of the major contributors to high [...]